Dialysis News and Research

Latest Dialysis News and Research

Affymax first quarter total revenue increases to $63.2 million

Affymax, Inc. today reported financial results for the first quarter ended March 31, 2012. The net income for the first quarter of 2012 was $31.5 million (or $0.87 per share) compared to a net loss of $9.6 million (or $(0.36) per share) for the first quarter of 2011.

8 May 2012

American CareSource launches ACS DiaSource solution for containment of dialysis costs

American CareSource Holdings, Inc. today introduced its new DiaSource solution for containment of dialysis costs. The solution is from Ancillary Care Services (ACS), the leading national network of ancillary healthcare providers and a wholly owned subsidiary of American CareSource.

7 May 2012

CSI third quarter revenues increase 5% to $21.2 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.

3 May 2012

Roundup: Mass. health cost control bill could save $8B to $34B; Md. weighs hospital rate freeze; Iowa Senate passes a fix for HIV insurance program

As Massachusetts' state legislators put the finishing touches on a major health care cost-control bill, there is still one big question: How much could it save? A recent report claims employers and employees could see between $8 billion and $34.5 billion in savings over nine years.

3 May 2012

Fish oil may improve outcomes for kidney patients undergoing hemodialysis

Over the past decade, there has been a steady stream of information promoting the health benefits of fish oil capsules. According to Dr. Louise Moist, a Scientist at Lawson Health Research Institute, fish oil may also improve outcomes for kidney patients undergoing hemodialysis.

2 May 2012

The skills of VA nurses under examination after patient deaths

Earlier this month, a broader review by the VA inspector general of 29 VA facilities found only half had adequately documented that their nurses had the needed skills. ... The April 20 IG report also noted that previous inspections had found nurse competency issues in "dialysis, mental health, long-term care, spinal cord injury, endoscopy procedure areas, the operating room and the cardiac catheterization laboratory and with reusable medical equipment.

2 May 2012

DaVita first quarter net income increases to $140.1 million

DaVita Inc. today announced results for the quarter ended March 31, 2012. Net income attributable to DaVita Inc. for the quarter ended March 31, 2012 was $140.1 million, or $1.46 per share.

2 May 2012

Roundup: Mass. premium increases muted; Iowa cuts payment to charity after fraud probe; Ga. asks EMS providers to save scarce drugs

State regulators on Monday approved third-quarter health insurance rates that will raise premiums an average of just 1.2 percent in the market serving small businesses and individuals, continuing a trend of more modest increases seen over the past three quarters. And several carriers, including Tufts Health Plan of Watertown and Fallon Community Health Plan, based in Worcester, will reduce their rates -- a rarity in Massachusetts health care -- according to data from the state Division of Insurance.

2 May 2012

Home-based dialysis more popular in developing countries

Researchers at Lawson Health Research Institute have discovered that developing countries have faster growing rates of use of home-based dialysis (called peritoneal dialysis) for kidney failure than the developed world. Despite home-based dialysis' reduced cost and better outcomes, developed countries (including Canada) are using this form of therapy less.

27 Apr 2012

Hemodiafiltration does not improve kidney failure patients' survival or heart health

A technique that removes additional toxins during dialysis does not improve kidney failure patients' survival or heart health, but intense treatments may provide a benefit, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

27 Apr 2012

Kidney donated two weeks after transplant

For the first time, a kidney that had been donated to a patient in need was removed and implanted into a new patient, the third individual to have the organ, after it failed in the first transplant recipient. Ray Fearing, a 27-year-old Arlington Heights resident received the organ from his sister, Cera, after a long battle with focal segmental glomerulosclerosis (FSGS), a disease in which scar tissue develops on the part of the kidney that filters waste out of the blood, ultimately causing kidney failure.

26 Apr 2012

Intensive dialysis at home could increase survival chances for patients with ESRD

Patients suffering with end-stage renal disease could increase their survival chances by undergoing intensive dialysis at home rather than the conventional dialysis in clinics. A new study by Lawson Health Research Institute shows the potential of more intensive dialysis completed in a home setting.

26 Apr 2012

Lophius Biosciences completes prospective multicenter clinical validation study for T-Track CMV/EBV tests

Lophius Biosciences, a leading developer of novel T-cell based diagnostic testing systems, today announces the successful completion of a prospective multicenter clinical validation study for its T-Track CMV/EBV tests.

25 Apr 2012

Nephros granted rights to market products based on Medica's Medisulfone ultrafiltration technology

Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and advanced water purification solutions, today announced that the company has entered into a strategic license and supply agreement with Medica S.p.A.

23 Apr 2012

Medgenics seeks FDA Orphan Drug Designation for INFRADURE to treat hepatitis D

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) for INFRADURE for the treatment of hepatitis D.

23 Apr 2012

JT/Torii report positive results from ferric citrate Phase 3 study for hyperphosphatemia

Keryx Biopharmaceuticals, Inc., announced today that its Japanese partner, Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd., has announced positive top-line results from a Phase 3 study of ferric citrate in Japan for the treatment of hyperphosphatemia in end-stage renal disease patients on hemodialysis.

23 Apr 2012

APS honors MCW professor with Henry Pickering Bowditch Lecture Award

High blood pressure, or hypertension, is a major problem worldwide, with the latest estimates suggesting that a billion people across the globe may have this condition. Hypertension not only takes an enormous cost on health and wellbeing, but it also exacts an expensive financial toll. Complications from this condition including kidney disease, and its resulting treatments, such as long-term dialysis and kidney transplant, are some of the costliest conditions the American health care system must contend with.

23 Apr 2012

Tengion completes FDA Pre-IND meeting for Neo-Kidney Augment preclinical program

Tengion, Inc., a leader in regenerative medicine, today announced that it recently completed a successful Pre-IND meeting with the U.S. Food and Drug Administration (FDA) for its lead preclinical program, the Neo-Kidney Augment.

18 Apr 2012

Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.

18 Apr 2012

Amgen enters agreement to acquire KAI Pharmaceuticals

Amgen and KAI Pharmaceuticals today announced an agreement under which Amgen will acquire KAI, a privately held pharmaceutical company based in South San Francisco.

11 Apr 2012

Dialysis News and Research

Latest Dialysis News and Research

Affymax first quarter total revenue increases to $63.2 million

American CareSource launches ACS DiaSource solution for containment of dialysis costs

CSI third quarter revenues increase 5% to $21.2 million

Roundup: Mass. health cost control bill could save $8B to $34B; Md. weighs hospital rate freeze; Iowa Senate passes a fix for HIV insurance program

Fish oil may improve outcomes for kidney patients undergoing hemodialysis

The skills of VA nurses under examination after patient deaths

DaVita first quarter net income increases to $140.1 million

Roundup: Mass. premium increases muted; Iowa cuts payment to charity after fraud probe; Ga. asks EMS providers to save scarce drugs

Home-based dialysis more popular in developing countries

Hemodiafiltration does not improve kidney failure patients' survival or heart health

Kidney donated two weeks after transplant

Intensive dialysis at home could increase survival chances for patients with ESRD

Lophius Biosciences completes prospective multicenter clinical validation study for T-Track CMV/EBV tests

Nephros granted rights to market products based on Medica's Medisulfone ultrafiltration technology

Medgenics seeks FDA Orphan Drug Designation for INFRADURE to treat hepatitis D

JT/Torii report positive results from ferric citrate Phase 3 study for hyperphosphatemia

APS honors MCW professor with Henry Pickering Bowditch Lecture Award

Tengion completes FDA Pre-IND meeting for Neo-Kidney Augment preclinical program

Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients

Amgen enters agreement to acquire KAI Pharmaceuticals

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Dialysis News and Research

Latest Dialysis News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in